Cochlear Future Growth
Future criteria checks 3/6
Cochlear is forecast to grow earnings and revenue by 11.9% and 8.9% per annum respectively. EPS is expected to grow by 11.9% per annum. Return on equity is forecast to be 25.3% in 3 years.
Key information
11.9%
Earnings growth rate
11.9%
EPS growth rate
Medical Equipment earnings growth | 16.2% |
Revenue growth rate | 8.9% |
Future return on equity | 25.3% |
Analyst coverage | Good |
Last updated | 19 Feb 2025 |
Recent future growth updates
Recent updates
Is Cochlear Limited (ASX:COH) Worth AU$310 Based On Its Intrinsic Value?
Feb 08Earnings Not Telling The Story For Cochlear Limited (ASX:COH)
Dec 20Some Investors May Be Worried About Cochlear's (ASX:COH) Returns On Capital
Nov 19Is Cochlear Limited (ASX:COH) Expensive For A Reason? A Look At Its Intrinsic Value
Nov 04We Think Shareholders May Consider Being More Generous With Cochlear Limited's (ASX:COH) CEO Compensation Package
Oct 18Cochlear Limited's (ASX:COH) Shareholders Might Be Looking For Exit
Sep 19Cochlear Limited Just Missed EPS By 7.4%: Here's What Analysts Think Will Happen Next
Aug 16Investors Could Be Concerned With Cochlear's (ASX:COH) Returns On Capital
Aug 01Here's Why We Think Cochlear (ASX:COH) Is Well Worth Watching
Jun 08Cochlear (ASX:COH) Might Be Having Difficulty Using Its Capital Effectively
Mar 27Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
6/30/2027 | 2,924 | 515 | 464 | 603 | 14 |
6/30/2026 | 2,665 | 436 | 378 | 514 | 15 |
6/30/2025 | 2,413 | 412 | 373 | 483 | 14 |
12/30/2024 | 2,309 | 371 | 251 | 342 | N/A |
9/30/2024 | 2,272 | 364 | 275 | 365 | N/A |
6/30/2024 | 2,236 | 357 | 299 | 389 | N/A |
3/31/2024 | 2,193 | 354 | 317 | 410 | N/A |
12/31/2023 | 2,149 | 350 | 335 | 430 | N/A |
9/30/2023 | 2,043 | 326 | 301 | 396 | N/A |
6/30/2023 | 1,936 | 301 | 267 | 362 | N/A |
3/31/2023 | 1,824 | 281 | 263 | 352 | N/A |
12/31/2022 | 1,713 | 261 | 259 | 341 | N/A |
9/30/2022 | 1,681 | 275 | 279 | 359 | N/A |
6/30/2022 | 1,648 | 289 | 299 | 377 | N/A |
3/31/2022 | 1,612 | 273 | 266 | 340 | N/A |
12/31/2021 | 1,575 | 257 | 233 | 304 | N/A |
9/30/2021 | 1,536 | 291 | 216 | 285 | N/A |
6/30/2021 | 1,498 | 324 | 199 | 265 | N/A |
3/31/2021 | 1,403 | 82 | -52 | 34 | N/A |
12/31/2020 | 1,308 | -160 | -302 | -198 | N/A |
9/30/2020 | 1,314 | -199 | -295 | -178 | N/A |
6/30/2020 | 1,321 | -238 | -288 | -158 | N/A |
3/31/2020 | 1,400 | 34 | -80 | 50 | N/A |
12/31/2019 | 1,479 | 306 | 128 | 259 | N/A |
9/30/2019 | 1,453 | 291 | 155 | 277 | N/A |
6/30/2019 | 1,427 | 277 | 181 | 296 | N/A |
3/31/2019 | 1,422 | 270 | 217 | 313 | N/A |
12/31/2018 | 1,418 | 264 | 252 | 330 | N/A |
9/30/2018 | 1,391 | 255 | N/A | 294 | N/A |
6/30/2018 | 1,364 | 246 | N/A | 258 | N/A |
3/31/2018 | 1,329 | 234 | N/A | 254 | N/A |
12/31/2017 | 1,294 | 223 | N/A | 250 | N/A |
9/30/2017 | 1,274 | 223 | N/A | 255 | N/A |
6/30/2017 | 1,254 | 224 | N/A | 260 | N/A |
3/31/2017 | 1,218 | 215 | N/A | 237 | N/A |
12/31/2016 | 1,182 | 206 | N/A | 214 | N/A |
9/30/2016 | 1,156 | 198 | N/A | 199 | N/A |
6/30/2016 | 1,131 | 189 | N/A | 185 | N/A |
3/31/2016 | 1,088 | 179 | N/A | 179 | N/A |
12/31/2015 | 1,045 | 168 | N/A | 172 | N/A |
9/30/2015 | 986 | 157 | N/A | 181 | N/A |
6/30/2015 | 926 | 146 | N/A | 189 | N/A |
3/31/2015 | 899 | 145 | N/A | 178 | N/A |
12/31/2014 | 872 | 144 | N/A | 168 | N/A |
9/30/2014 | 839 | 119 | N/A | 140 | N/A |
6/30/2014 | 805 | 94 | N/A | 111 | N/A |
3/31/2014 | 769 | 85 | N/A | 93 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: COH's forecast earnings growth (11.9% per year) is above the savings rate (2.7%).
Earnings vs Market: COH's earnings (11.9% per year) are forecast to grow slower than the Australian market (12% per year).
High Growth Earnings: COH's earnings are forecast to grow, but not significantly.
Revenue vs Market: COH's revenue (8.9% per year) is forecast to grow faster than the Australian market (5.7% per year).
High Growth Revenue: COH's revenue (8.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: COH's Return on Equity is forecast to be high in 3 years time (25.3%)
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/02/21 04:54 |
End of Day Share Price | 2025/02/21 00:00 |
Earnings | 2024/12/30 |
Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Cochlear Limited is covered by 29 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
John Hester | ANZ Equities Pty Limited |
Saul Hadassin | Barrenjoey Markets Pty Limited |
Stuart Roberts | Bell Potter |